Stage IV Lung Cancer Patient Story
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Sex
- Male
- Spread to
- Bone
- Treatment
- targeted therapy and supportive care
- Outcome
- Setback / Progression
Treatment course, step by step
- AZD9291 was the current treatment in this post
- Patient worried the next CT might show AZD9291 was no longer working
- Severe bone-metastasis pain was managed with fentanyl patches and morphine tablets
- Maintenance chemotherapy every 21 days was mentioned only as a possible future option
- No active chemotherapy was confirmed in this post.
What happened, in summary
About 3 years after learning he had lung cancer, this Spanish blogger wrote a farewell post from a much harder point in the illness. Recent months had brought bone metastases, pneumonia, severe pain, feverish evenings, night sweats, low-oxygen episodes, and the isolation of being mostly at home. A bone scan had confirmed that bone lesions had moved to the right side, although it did not give much detail about size or extent. His next CT scan was expected to clarify the situation. Pain had become one of the dominant problems. His oncology team prescribed fentanyl patches, described as a synthetic morphine, and morphine tablets, but he was still trying to balance relief against the risk of being too sedated to get out of bed. AZD9291 was still part of the picture, but he worried that new CT progression would mean it was no longer working. He expected that maintenance chemotherapy every 21 days might be considered if his body could tolerate it. By March 2017, he was facing a clear setback, ending the blog to focus on dignity, comfort, and the people who had supported him.
Where this story comes from
This is a lay summary of an account first published by Noxte (Blog Cáncer de Pulmón). Read the original in full
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team.